Ilan Ganot, CEO & President at Solid Biosciences Inc. (SLDB), sold 463 shares at $1.12 ($519) on 2022-02-10, disclosed to the SEC on 2022-03-08.
Scheduled sale ($519) by CEO & President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SLDB | SELL | 2026-01-30 | $1K | — | Filing → |
| SLDB | SELL | 2026-01-06 | $6K | — | Filing → |
| SLDB | SELL | 2025-11-13 | $14K | — | Filing → |